Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data-Reference-Cited by-同舟云学术

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

Published:2009-04 Issue:4 Volume:10 Page:341-350
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Michiels Stefan,Le Maître Aurélie,Buyse Marc,Burzykowski Tomasz,Maillard Emilie,Bogaerts Jan,Vermorken Jan B,Budach Wilfried,Pajak Thomas F,Ang Kian K,Bourhis Jean,Pignon Jean-Pierre

Publisher

Elsevier BV

Subject

Oncology

Reference114 articles.

1. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase, No 5, version 20;Ferlay,2004

2. Cancer statistics, 2000;Greenlee;CA Cancer J Clin,2000

3. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study;Berrino;Lancet Oncol,2007

4. Head and neck cancer;Vokes;N Engl J Med,1993

5. Chemoradiotherapy for locally advanced head and neck cancer;Salama;J Clin Oncol,2007

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. A novel approach to the analysis of Overall Survival (OS) as response with Progression-Free Interval (PFI) as condition based on the RNA-seq expression data in The Cancer Genome Atlas (TCGA);BMC Bioinformatics;2024-09-13

3. Evaluation of Time-to-event Surrogate Endpoint Endpoint ─Meta-analytic Approach─;Japanese Journal of Biometrics;2024-07-30

4. Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations;The Lancet Oncology;2024-07

5. Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations;The Lancet Oncology;2024-07